论文部分内容阅读
目的探究匹多莫德在小儿反复呼吸道感染治疗中的疗效观察和作用分析。方法从2010年1月～2011年1月于我院治疗反复上呼吸道感染患儿病例100例,随机将患儿分为两组,分别为TG组和OG组,每组50例。两组患儿均进行常规治疗,TG组加用匹多莫德治疗,比较两组患儿6个月内呼吸道感染次数、临床症状等指标。结果 TG组显效21例,有效25例,总有效率92%,OG组显效10例,有效23例,总有效率66%,两组存在明显差异,具有统计学意义(P<0.05)。结论匹多莫德在提高患儿免疫力方面效果显著,临床配合常规治疗使用可以明显减少患儿呼吸道感染复发率,缩短病程,值得临床推广。
Objective To investigate the efficacy and effect of pidotimod in children with recurrent respiratory tract infections. Methods From January 2010 to January 2011, 100 cases of children with recurrent upper respiratory tract infection were treated in our hospital. The children were randomly divided into two groups: TG group and OG group, 50 cases in each group. Two groups of children were treated routinely, TG group with pidotimod treatment, two groups of children within 6 months of respiratory tract infections, clinical symptoms and other indicators. Results In TG group, 21 cases were markedly effective and 25 cases were effective. The total effective rate was 92%. In OG group, 10 cases were markedly effective and 23 cases were effective. The total effective rate was 66%. There was significant difference between the two groups (P <0.05). Conclusion Pidotimod is effective in improving children ’s immunity. Clinically, in combination with routine treatment, the relapse rate and shortening of the course of respiratory infection in children can be significantly reduced, which is worthy of clinical promotion.